Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2002Pathology Patterns Reviews

Cardiac Markers for Myocardial Infarction

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with chest pain being evaluated for myocardial infarction

Design

Review

Authors

KLKent LewandrowskiBoston UniversityACAhchean ChenVA Boston Healthcare System
James L. Januzzi
James L. JanuzziHeart Failure / Cardiomyopathy

Discussion

Loading...

Member takes

Implication

Supports updated MI biomarker guidelines in practice; leaves open prospective validation of point-of-care testing.

Structured PICO

P
Population
Patients with chest pain being evaluated for myocardial infarction
I
Intervention
Cardiac biomarker testing, including point-of-care testing

This review provides an overview of updated guidelines for the use of cardiac biomarkers in diagnosing myocardial infarction and their integration into clinical practice.

Cite This Study

Lewandrowski et al. (2002) studied this question.

synapsesocial.com/papers/6a90ea66cd6c08c0eacae71dhttps://doi.org/10.1309/3ek7-yvv9-228c-e1xt
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction2000 · 4,856 citations
  2. 2Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia1996 · 1,131 citations
  3. 3Use of a Rapid Assay of Subforms of Creatine Kinase MB to Diagnose or Rule Out Acute Myocardial Infarction1994 · 327 citations
  4. 4National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases1999 · 664 citations
  5. 5The need for a point of care testing: An evidence-based appraisal1999 · 44 citations